Medimix Hematology
  • Home
  • Live from the congress
    • 2025
      • EBMT 2025
    • 2024
      • ASH 2024 (San Diego)
      • EHA 2024 (Madrid)
      • ASCO 2024 (Chicago)
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
  • SIGN UP
  • SIGN IN
    • Login
ASCO 2023

Highlights from ASCO

June 5, 2023

Dr Claudio Cerchione, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy, summarised the educational session on the management of multiple myeloma in special patient populations, such as elderly and patients with renal failure. He discussed optimal treatment selection based on patient needs and toxicity management. 

With the educational support of:

Tags:

highlight

Share Article

Medimix Hematology

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Live from the congress
    • 2025
      • EBMT 2025
    • 2024
      • ASH 2024 (San Diego)
      • EHA 2024 (Madrid)
      • ASCO 2024 (Chicago)
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
  • SIGN UP
  • SIGN IN
    • Login
    • Logout